Y-Intercept (HK)’s Ionis Pharmaceuticals IONS Stock Holding History

Y-Intercept (HK)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.34M	Buy	+67,374	New	+$5.07M	0.11%	259
2025 Q3	–	Sell	-37,649	Closed	-$1.49M	–	1788
2025 Q2	$1.49M	Buy	+37,649	New	+$1.23M	0.04%	744
2025 Q1	–	Sell	-9,407	Closed	-$329K	–	1399
2024 Q4	$329K	Sell	9,407 -10,734	-53%	-$401K	0.02%	904
2024 Q3	$807K	Buy	+20,141	New	+$937K	0.05%	537
2023 Q4	–	Sell	-8,803	Closed	-$399K	–	1428
2023 Q3	$399K	Buy	+8,803	New	+$363K	0.04%	648
2022 Q2	–	Sell	-10,689	Closed	-$396K	–	1019
2022 Q1	$396K	Buy	+10,689	New	+$350K	0.09%	356

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Y-Intercept (HK)'s IONS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 67,374 shares worth $5.34M. The stake represents 0.11% of the portfolio and ranks #259 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in IONS as recently as Q2 2025.

Y-Intercept (HK) first reported a position in IONS in Q1 2022 and has held it in 6 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Y-Intercept (HK) held 67,374 shares of Ionis Pharmaceuticals worth $5.34M as of Q2 2026.
Ionis Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
Ionis Pharmaceuticals made up 0.11% of Y-Intercept (HK)'s portfolio in Q2 2026, its #259 holding.
Y-Intercept (HK) first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.